Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 218 M221 M225 M241 M225 M 912 M Research & development ————— — Operating income 1.46 B859 M816 M1.21 B1.72 B 4.6 B Non-Operating Income, Total -21 M18 M-2 M1.18 B26 M 1.23 B Interest expense, net of interest capitalized 206 M212 M206 M191 M179 M 788 M Non-Operating Income, excl. Interest Expenses -217 M-250 M-195 M-186 M-158 M -789 M Unusual income/expense -10 M56 M-13 M1.18 B5 M 1.23 B Pretax income 1.25 B703 M597 M2.21 B1.55 B 5.06 B Equity in earnings -2 M3 M4 M5 M0 12 M Taxes 268 M109 M127 M505 M314 M 1.05 B Non-controlling/minority interest 17 M15 M12 M11 M27 M 65 M After tax other income/expense 17 M94 M5 M17 M-1 M 115 M Net income before discontinued operations 965 M579 M458 M1.69 B1.21 B 3.94 B Discontinued operations ————— — Net income 965 M579 M458 M1.69 B1.21 B 3.94 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 965 M579 M458 M1.69 B1.21 B 3.94 B Basic earnings per share (Basic EPS) 4.462.682.127.855.66 18.31 Diluted earnings per share (Diluted EPS) 4.432.662.117.825.63 18.22 Average basic shares outstanding 216.4 M216.2 M215.7 M215.9 M214.3 M — Diluted shares outstanding 217.9 M217.3 M216.7 M217.1 M215.4 M — EBITDA 1.51 B906 M863 M1.26 B1.76 B 4.79 B EBIT 1.46 B859 M816 M1.21 B1.72 B 4.6 B Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 46 M47 M47 M48 M46 M 188 M